Basic Information
| LncRNA/CircRNA Name | LINC00963 |
| Synonyms | NA |
| Region | GRCh38_9:129483451-129513686 |
| Ensemble | ENSG00000204054 |
| Refseq | NR_038955 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | PCR |
| Sample | OS tissues,OS cell lines (MG63, U2OS,HOS, Saos-2) |
| Expression Pattern | up-regulated |
| Function Description | In this study, wefound that LINC00963 was highly expressed in osteosarcoma tissues and cell lines. Poor prognosis was found in patients with relatively high LINC00963 expression. |
| Pubmed ID | 30975024 |
| Year | 2019 |
| Title | The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis. |
External Links
| Links for LINC00963 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |